AUS
NZ
UK
CA
USA
IND
Healthcare
DAYBUE Momentum Signals a New Growth Phase for Neuren
January 14, 2026 03:47 PM AEDT| By SamNeuren Pharmaceuticals advances its global presence as DAYBUE adoption grows, supported by innovation, patient access expansion, and international regulatory milestones shaping long-term healthcare relevance.
Insider Activity at Microba Life Sciences Draws Market Focus
January 14, 2026 03:19 PM AEDT| By SamAn in-depth look at insider ownership trends at Microba Life Sciences, examining governance signals, shareholder alignment, and broader implications within the Australian equity environment.
Why ASX 200 Healthcare Eyes Are Fixed on CSL’s Next Update
January 14, 2026 02:37 PM AEDT| By SamCSL remains a central figure in Australia’s healthcare narrative, with upcoming disclosures shaping sentiment across valuation, innovation, and long-term sector confidence.
Echo IQ Limited Advances Within Australia’s AI Diagnostics Sector
January 13, 2026 05:41 PM AEDT| By SamEcho IQ Limited (ASX:EIQ) focuses on AI diagnostics for structural heart disease, maintaining equity-funded operations and notable inclusion in the All Ordinaries.
Cochlear (ASX:COH) Expands US VA Access, ASX 50 Hearing Tech
January 13, 2026 05:35 PM AEDT| By SamAnalysis of Cochlear focusing on Nucleus Nexa system expansion, technology differentiation, and ASX 50 sector positioning, providing a factual view of operational and clinical developments.
Healthcare Technology Spotlight Builds Within All Ordinaries Index
January 13, 2026 04:42 PM AEDT| By SamFour D Medical remains part of Australia’s healthcare technology landscape, with index inclusion and sector activity highlighting its role within the ASX framework.
Healius (ASX:HLS) Shares Steady Within ASX 300 Healthcare Services
January 13, 2026 04:28 PM AEDT| By SamNeutral discussion of Healius Limited healthcare services model, operational scope, and industry context, outlining sector participation and ASX 300 classification without directional or promotional language.
Insider Ownership Signals Strength in Sigma Healthcare on asx 200
January 13, 2026 03:12 PM AEDT| By SamInsider alignment at Sigma Healthcare highlights governance strength, strategic consistency, and the importance of ownership structures when assessing healthcare companies in the Australian share market.
ASX 200 Spotlight: Why Ansell’s Latest Shift Has Markets Watching
January 13, 2026 02:55 PM AEDT| By SamAnsell’s leadership transition highlights how healthcare manufacturers navigate valuation scrutiny and market recalibration within Australia’s major equity benchmarks.
FDA clearance lifts cloud healthcare tech momentum on ASX
January 13, 2026 12:32 PM AEDT| By SamUS regulatory clearance strengthens Singular Health’s cloud imaging strategy, highlighting how Australian healthcare innovators are expanding globally through compliant, scalable digital solutions.
Why Echo IQ’s AI Healthcare Path Is Gaining Market Attention
January 13, 2026 11:42 AM AEDT| By SamEcho IQ’s AI-driven healthcare model highlights disciplined growth, clinical relevance, and financial stability within Australia’s evolving medical technology landscape.
Lumos Diagnostics Advances US Strategy With FebriDx
January 12, 2026 07:34 PM AEDT| By SamLumos Diagnostics advances its US healthcare presence through regulatory milestones, reimbursement coverage and global expansion, reinforcing its role in point-of-care diagnostics across major medical markets.
4DMedical (ASX:4DX) Aligns Governance Within All Ordinaries
January 12, 2026 04:20 PM AEDT| By SamHealthcare imaging overview detailing 4DMedical Limited activities, regulatory context, partnerships, and positioning within the All Ordinaries healthcare segment.
ASX 200 Today Director Activity Overview Across Key Listed Sectors
January 12, 2026 04:19 PM AEDT| By SamOverview of director share disclosures across ASX 200 companies spanning healthcare, energy, infrastructure, and digital services within major Australian indices.
Cochlear (ASX:COH) Shares Steady as Firm Holds ASX 50 Spot
January 12, 2026 04:10 PM AEDT| By SamOverview of Cochlear Limited covering sector role, operational structure, global presence, and index classification within Australian healthcare manufacturing landscape.
Clinuvel Pushes Innovation With Injectable Platform Progress
January 12, 2026 03:44 PM AEDT| By SamClinuvel Pharmaceuticals advances its injectable research program as a new platform enters preclinical evaluation, reflecting steady innovation, pipeline development, and growing interest across the Australian share market.
Breakthrough Cancer Study Puts Australian Biotech in Global Spotlight
January 12, 2026 03:37 PM AEDT| By SamAn in-depth look at how an Australian biotechnology company is advancing pancreatic cancer research through clinical trials, global scientific engagement, and targeted drug development strategies.
Why Market Perception Around Alcidion Group Is Quietly Changing
January 12, 2026 02:43 PM AEDT| By SamA closer look at how changing valuation assumptions are reshaping market perception around Alcidion Group within Australia’s healthcare technology landscape.
Leadership Shift Reshapes 4DMedical’s Market Narrative
January 12, 2026 11:44 AM AEDT| By SamThis article explores how a leadership transition at 4DMedical is reshaping its market narrative, strengthening governance, and aligning financial oversight with commercial expansion.
ASX 200 spotlight as Clinuvel advances next-gen drug delivery platform
January 12, 2026 11:42 AM AEDT| By SamClinuvel Pharmaceuticals advances an internally developed peptide delivery platform, highlighting Australian biotechnology innovation and reinforcing the strategic role of healthcare companies within the evolving domestic equity landscape.
Advertise your brand on Kalkine Media